Xiao-yuan Zeng1 article listing Xiao-yuan Zeng in Nature Communications, indexed by Paperzzz from Crossref and OSF.Quizartinib and omacetaxine mepesuccinate combination therapy in FLT3-ITD AML: a phase II trial Nature Communications